Life Sciences
An Experienced Hand Launches 3 ETFs Under His Own Flag
ETF veteran Kevin Kelly is the force behind Kelly ETFs, which this month introduced three funds with distinctly different focuses.
Johnson & Johnson May Shed Some Tears in This Bear Market Decline
JNJ has been in a longer-term uptrend but that may not be enough to keep the rally going.
Intuitive Surgical Has Broken Down From a Triple Top Formation
Let's review the charts and indicators.
Illumina's Charts Are Brightening Up
Here's how to approach this life-sciences company.
Edwards Lifesciences Could Pump Out New Highs Soon
The technical signs of the maker of heart valve systems and repair products indicate its shares could strengthen.
Our Updated Strategy as AbbVie Finally Breaks Out to New Highs
The bulls are back in charge.
Here's My Risk and Reward Parameters for Vir Biotechnology
Let's look over the charts and indicators.
Karuna Therapeutics Is Doing Important Research but Its Charts Are Weak
The technical signals of the clinical-stage biotech company don't inspire confidence at this juncture.
Thrill Seekers Might Like 2 Downtrodden Stocks Insiders Are Buying
TherapeuticsMD and Spark Networks are beaten-down names with recent buying interest from insiders in common.
Veeva Systems Doesn't Look so Alive
According to the charts, VEEV appears weak and prone to further declines ahead of earnings.